Trial Profile
A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt), Each Administered as a Single Oral Dose
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferitazole (Primary)
- Indications Iron overload
- Focus Pharmacokinetics
- Sponsors Shire
- 01 Jun 2021 Planned End Date changed from 1 Mar 2014 to 19 Mar 2014.
- 01 Jun 2021 Planned primary completion date changed from 1 Mar 2014 to 19 Mar 2014.
- 01 Jun 2021 Planned initiation date changed from 1 Feb 2014 to 28 Feb 2014.